Source link : https://www.newshealth.biz/health-news/nhs-will-not-fund-new-drug-to-slow-alzheimers/
A new drug that slows the pace of Alzheimer’s disease is too expensive for too little benefit to be used on the NHS, the drugs spending watchdog says. Donanemab was hailed as a turning point in the disease last year. But the National Institute of Health and Care Excellence (NICE) said it provided only a […]
Author : News Health
Publish date : 2024-10-23 09:02:04
Copyright for syndicated content belongs to the linked Source.